Home » Topics » Regulatory » Patents

Patents
RSS

Novel agents for treating eating disorders claimed by sanofi-aventis

Aug. 23, 2005

New agents for arthritis, inflammatory disorders, etc., in early development

Aug. 22, 2005

Novel agents for respiratory disorders claimed in recent patents

Aug. 22, 2005

New anti-HCV agents prepared and tested

Aug. 22, 2005

Novel antiglaucoma agents jointly disclosed by Ube and Santen

Aug. 18, 2005

Vanilloid VR1 receptor modulators emerge from recent R&D

Aug. 18, 2005

Recent patents cover novel treatments for cognitive disorders

Aug. 18, 2005

Therapeutic agents for arthritis and other musculoskeletal diseases prepared and tested

Aug. 17, 2005

Recent patents reveal novel agents for respiratory diseases

Aug. 17, 2005

New therapeutics for cancer disclosed in recent patent literature

Aug. 17, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...